Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
This study will determine whether lenalidomide has activity in patients with advanced liver
cancer that have had growth of their cancer after sorafenib.
Phase:
Phase 2
Details
Lead Sponsor:
Brown University
Collaborators:
Memorial Hospital of Rhode Island Roger Williams Medical Center